2015 Q2 Form 10-Q Financial Statement
#000119312515285056 Filed on August 10, 2015
Income Statement
Concept | 2015 Q2 | 2014 Q2 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | $5.700M | |
YoY Change | ||
Gross Profit | -$5.700M | |
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $10.62M | $32.50M |
YoY Change | -67.31% | 124.14% |
% of Gross Profit | ||
Research & Development | $7.737M | $37.32M |
YoY Change | -79.27% | 37.97% |
% of Gross Profit | ||
Depreciation & Amortization | $2.740M | $2.449M |
YoY Change | 11.88% | -17.15% |
% of Gross Profit | ||
Operating Expenses | $24.05M | $69.85M |
YoY Change | -65.57% | 67.96% |
Operating Profit | -$24.05M | -$69.85M |
YoY Change | -65.57% | 67.96% |
Interest Expense | -$4.800M | -$3.100M |
YoY Change | 54.84% | -32.61% |
% of Operating Profit | ||
Other Income/Expense, Net | -$10.00K | -$370.0K |
YoY Change | -97.3% | -2566.67% |
Pretax Income | -$28.91M | -$73.37M |
YoY Change | -60.59% | 59.06% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$28.91M | -$73.37M |
YoY Change | -60.59% | 59.06% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$360.3K | -$892.9K |
COMMON SHARES | ||
Basic Shares Outstanding | 409.6M shares | 388.6M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2015 Q2 | 2014 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $107.2M | $41.20M |
YoY Change | 160.19% | 44.56% |
Cash & Equivalents | $107.2M | $41.21M |
Short-Term Investments | ||
Other Short-Term Assets | $14.10M | $3.700M |
YoY Change | 281.08% | 15.63% |
Inventory | $19.82M | |
Prepaid Expenses | ||
Receivables | $4.748M | |
Other Receivables | $0.00 | |
Total Short-Term Assets | $145.8M | $44.91M |
YoY Change | 224.71% | 39.64% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $193.9M | $183.5M |
YoY Change | 5.63% | 2.21% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $2.025M | $7.400M |
YoY Change | -72.64% | 3117.39% |
Total Long-Term Assets | $206.7M | $191.4M |
YoY Change | 8.01% | 6.17% |
TOTAL ASSETS | ||
Total Short-Term Assets | $145.8M | $44.91M |
Total Long-Term Assets | $206.7M | $191.4M |
Total Assets | $352.6M | $236.3M |
YoY Change | 49.19% | 11.24% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $5.190M | $5.086M |
YoY Change | 2.04% | -6.15% |
Accrued Expenses | $13.93M | $20.58M |
YoY Change | -32.31% | -23.74% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $73.80M | $37.70M |
YoY Change | 95.76% | -68.48% |
Long-Term Debt Due | $64.10M | |
YoY Change | ||
Total Short-Term Liabilities | $342.3M | $119.2M |
YoY Change | 187.05% | -55.31% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $113.6M | $148.4M |
YoY Change | -23.45% | 51.43% |
Other Long-Term Liabilities | $12.12M | $15.04M |
YoY Change | -19.39% | |
Total Long-Term Liabilities | $12.12M | $15.04M |
YoY Change | -19.39% | -84.65% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $342.3M | $119.2M |
Total Long-Term Liabilities | $12.12M | $15.04M |
Total Liabilities | $468.0M | $282.7M |
YoY Change | 65.57% | -22.51% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$2.554B | |
YoY Change | ||
Common Stock | $2.439B | $2.375B |
YoY Change | 2.67% | 16.46% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$115.5M | -$46.38M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $352.6M | $236.3M |
YoY Change | 49.19% | 11.24% |
Cashflow Statement
Concept | 2015 Q2 | 2014 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$28.91M | -$73.37M |
YoY Change | -60.59% | 59.06% |
Depreciation, Depletion And Amortization | $2.740M | $2.449M |
YoY Change | 11.88% | -17.15% |
Cash From Operating Activities | -$17.81M | -$23.42M |
YoY Change | -23.95% | -21.25% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$4.540M | -$8.260M |
YoY Change | -45.04% | 6253.85% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | |
YoY Change | ||
Cash From Investing Activities | -$4.540M | -$8.260M |
YoY Change | -45.04% | 6253.85% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 8.680M | 37.13M |
YoY Change | -76.62% | 22.14% |
NET CHANGE | ||
Cash From Operating Activities | -17.81M | -23.42M |
Cash From Investing Activities | -4.540M | -8.260M |
Cash From Financing Activities | 8.680M | 37.13M |
Net Change In Cash | -13.67M | 5.450M |
YoY Change | -350.83% | 928.3% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$17.81M | -$23.42M |
Capital Expenditures | -$4.540M | -$8.260M |
Free Cash Flow | -$13.27M | -$15.16M |
YoY Change | -12.47% | -48.8% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2015Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
414033866 | shares |
CY2014Q2 | us-gaap |
Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
|
9000000 | shares |
CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
41214000 | |
CY2015Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2015Q2 | us-gaap |
Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
|
9000000 | shares |
CY2015Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2015Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
550000000 | shares |
CY2015Q2 | us-gaap |
Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
|
9000000 | shares |
CY2015Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
412316619 | shares |
CY2015Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2015Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2015Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
412316619 | shares |
CY2015Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2015Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
342254000 | |
CY2015Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
8455000 | |
CY2015Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
123154000 | |
CY2015Q2 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
49521000 | |
CY2015Q2 | us-gaap |
Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
|
28415000 | |
CY2015Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13930000 | |
CY2015Q2 | us-gaap |
Construction Payable Current
ConstructionPayableCurrent
|
42000 | |
CY2015Q2 | us-gaap |
Assets Current
AssetsCurrent
|
145827000 | |
CY2015Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
16038000 | |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
107187000 | |
CY2015Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
3757000 | |
CY2015Q2 | us-gaap |
Assets
Assets
|
352551000 | |
CY2015Q2 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
30100000 | |
CY2015Q2 | us-gaap |
Liabilities
Liabilities
|
468026000 | |
CY2015Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
35713000 | |
CY2015Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
4121000 | |
CY2015Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2434777000 | |
CY2015Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
2396000 | |
CY2015Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
12123000 | |
CY2015Q2 | us-gaap |
Other Long Term Debt Current
OtherLongTermDebtCurrent
|
73757000 | |
CY2015Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
171850000 | |
CY2015Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-20000 | |
CY2015Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
64123000 | |
CY2015Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
244900000 | |
CY2015Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2015Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2015Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3037000 | |
CY2015Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2554353000 | |
CY2015Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-115475000 | |
CY2015Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
352551000 | |
CY2015Q2 | us-gaap |
Other Deferred Credits Current
OtherDeferredCreditsCurrent
|
13404000 | |
CY2015Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5190000 | |
CY2015Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
21000 | |
CY2015Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
193868000 | |
CY2015Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
14076000 | |
CY2015Q2 | us-gaap |
Deferred Costs
DeferredCosts
|
10831000 | |
CY2015Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4748000 | |
CY2015Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
317022000 | |
CY2015Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
2025000 | |
CY2015Q2 | us-gaap |
Inventory Net
InventoryNet
|
19816000 | |
CY2015Q2 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
104700000 | |
CY2015Q2 | mnkd |
Potential Proceeds From Warrant Exercises
PotentialProceedsFromWarrantExercises
|
9800000 | |
CY2015Q2 | mnkd |
Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
|
9000000 | shares |
CY2015Q2 | mnkd |
Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
|
0 | |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
70790000 | |
CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
550000000 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
406059089 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
406059089 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-73770000 | |
CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
394439000 | |
CY2014Q4 | us-gaap |
Other Deferred Credits Current
OtherDeferredCreditsCurrent
|
436000 | |
CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
7394000 | |
CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
403353000 | |
CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
14928000 | |
CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
118221000 | |
CY2014Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
49521000 | |
CY2014Q4 | us-gaap |
Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
|
3034000 | |
CY2014Q4 | us-gaap |
Construction Payable Current
ConstructionPayableCurrent
|
1343000 | |
CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
26206000 | |
CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
468209000 | |
CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4061000 | |
CY2014Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2416967000 | |
CY2014Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
2396000 | |
CY2014Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
12301000 | |
CY2014Q4 | us-gaap |
Other Long Term Debt Current
OtherLongTermDebtCurrent
|
72995000 | |
CY2014Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
196967000 | |
CY2014Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-14000 | |
CY2014Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
99355000 | |
CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2014Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2014Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
7539000 | |
CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2494784000 | |
CY2014Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
95000 | |
CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
192127000 | |
CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
201153000 | |
CY2014Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
4856000 | |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
120841000 | |
CY2014Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
4719000 | |
CY2014Q4 | us-gaap |
Assets
Assets
|
394439000 | |
CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
20206000 | |
CY2014Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
50436000 | |
CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
310348000 | |
CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1159000 | |
CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
9670000 | |
CY2014Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
118500000 | |
CY2014Q4 | mnkd |
Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
|
9000000 | shares |
CY2014Q3 | us-gaap |
Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
|
120100000 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
56844341 | shares | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-60408000 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.33 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
374810000 | shares | |
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
296000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
450000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-29576000 | ||
us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
1435000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-9667000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-3315000 | ||
mnkd |
Write Off Of Derivative Liability
WriteOffOfDerivativeLiability
|
363000 | ||
mnkd |
Non Cash Financing Activities Loan Commitment Asset
NonCashFinancingActivitiesLoanCommitmentAsset
|
1753000 | ||
mnkd |
Reclassification Of Share Based Awards To Liability
ReclassificationOfShareBasedAwardsToLiability
|
19926000 | ||
mnkd |
Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
|
20622000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-125422000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
9667000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
|
0 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-6260000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-111258000 | ||
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
0 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-125422000 | ||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
0 | ||
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2000 | ||
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
123000 | ||
us-gaap |
Interest Paid
InterestPaid
|
5296000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1789000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-125422000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | ||
us-gaap |
Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
|
2965000 | ||
us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
93500000 | ||
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
12614000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
111258000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
40499000 | ||
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
0 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4972000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
47752000 | ||
us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
63506000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
|
0 | ||
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
6471000 | ||
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
20000000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
51583000 | ||
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1435000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1567000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
51583000 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
45790000 | ||
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
6624000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
9872000 | ||
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
0 | ||
us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <b><i>Deferred product costs from collaboration —</i></b> Deferred product costs represent the costs of product manufactured and sold to Sanofi, as long as they are not greater than the amount of deferred product sales related to the collaboration, for which recognition of revenue has been deferred. Given that the costs of inventory delivered to a customer, but for which revenue may not yet be recognized, meet both the definition and characteristics of an “asset” and the Company believes that it is probable that the amount of future revenue will exceed the amount of deferred costs (i.e., the asset would be realizable through the recognition of probable future income), the Company has elected to account for the deferred costs related to the product sold to Sanofi as an asset and carry forward to future periods until the related revenue is recognized.</p> </div> | ||
dei |
Trading Symbol
TradingSymbol
|
MNKD | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000899460 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2015-06-30 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
40982544 | shares | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5117000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
21102000 | ||
us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
17115000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
12968000 | ||
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1465000 | ||
us-gaap |
Manufacturing Costs
ManufacturingCosts
|
7573000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2236000 | ||
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
40000 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y7M6D | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-14789000 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.15 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
MANNKIND CORP | ||
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-12000 | ||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
0 | ||
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6000 | ||
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
818000 | ||
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-6000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | ||
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-6000 | ||
us-gaap |
Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
|
623000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2050000 | ||
us-gaap |
Interest Paid
InterestPaid
|
6644000 | ||
us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-45688000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-6130000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-59569000 | ||
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
6000 | ||
us-gaap |
Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
|
10831000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-59575000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
|
0 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
481000 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
399972000 | shares | |
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2015 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
866000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
8737000 | ||
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
|
0 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1403000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-45790000 | ||
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
0 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
10146000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-59569000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-13654000 | ||
us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
1435000 | ||
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
13753000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3778000 | ||
CY2014Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
0 | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3778000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-8737000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-7800000 | ||
mnkd |
Nominal Lending Fee
NominalLendingFee
|
0.01 | ||
mnkd |
Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
|
P4Y | ||
mnkd |
Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
|
12820000 | ||
mnkd |
Milestone Payments
MilestonePayments
|
4220000 | ||
CY2015Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
36300 | shares |
CY2015Q1 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
73600 | shares |
CY2014Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.19 | |
CY2014Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
380770000 | shares |
CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-73365000 | |
CY2014Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-370000 | |
CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-69846000 | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
0 | |
CY2014Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1000 | |
CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-73365000 | |
CY2015Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
0 | |
CY2015Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
3000 | |
CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-73365000 | |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28910000 | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
1000 | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1000 | |
CY2015Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
24051000 | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
0 | |
CY2015Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-28910000 | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | |
CY2014Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
69846000 | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
0 | |
CY2014Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2449000 | |
CY2014Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2014Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
32523000 | |
CY2014Q2 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
37323000 | |
CY2014Q2 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
227000 | |
CY2014Q2 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
721000 | |
CY2014Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
2429000 | |
CY2014Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
40644000 | |
CY2015Q2 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
194704 | shares |
CY2015Q2 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
208000 | shares |
CY2015Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
CY2015Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
401018000 | shares |
CY2015Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-28909000 | |
CY2015Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-10000 | |
CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24051000 | |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
0 | |
CY2015Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2740000 | |
CY2015Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2015Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10623000 | |
CY2015Q2 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
7737000 | |
CY2015Q2 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
243000 | |
CY2015Q2 | us-gaap |
Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
721000 | |
CY2015Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
4131000 | |
CY2015Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1775000 | |
CY2015Q2 | us-gaap |
Manufacturing Costs
ManufacturingCosts
|
5691000 |